DIAGNOSTIC_TEST · Unmapped registry intervention
Fluoro[18F]promethazine
Find medicine records ·
Find other trials using this name
Clinical trial
AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease
NCT06456684
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson Diseaseverified · MONDO: Parkinson disease
Interventions
Fluoro[18F]promethazineDIAGNOSTIC_TEST
Sponsors & collaborators
Xuanwu Hospital, Beijinglead sponsor
XingImaging, LLCcollaborator
Naming MITRO Pharmaceutical Technology Co., Ltdcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06456684 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.